首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1414303

2024 年免疫診斷全球市場報告

Immunodiagnostics Global Market Report 2024

出版日期: 2024年01月19日 | 出版商:

The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

近年來，免疫診斷市場規模一直強勁成長。將從2023年的213億美元成長到2024年的229億美元，複合年成長率為7.5%。過去一段時間的擴張歸因於感染疾病的增加、自體自體免疫疾病的增加、癌症診斷和監測、感染疾病的全球化以及公共衛生努力和篩檢計畫的實施。

免疫診斷市場規模預計在未來幾年將強勁成長。到 2028 年，將以 7.8% 的年複合成長率（CAGR）成長至 309 億美元。預測期內的預期成長是由大流行病防範和應對、個性化醫療和生物標記發現的進步、新興市場醫療保健基礎設施的擴展、與實驗室資訊系統的整合以及慢性病負擔的增加所推動的。預測期內預計的主要趨勢包括多重技術的採用、即時檢測 (POCT) 的出現、生物標記發現和個人化醫療的進步、數位免疫診斷的興起以及向液體活體組織切片的轉變。提及。

在可預見的未來，感染疾病患者的預期增加可能會推動免疫診斷市場的成長。感染疾病的特徵是病毒、細菌、真菌和寄生蟲等病菌在個體之間傳播，可以透過檢測血液樣本中是否有病毒的免疫診斷分析來識別。免疫診斷市場預計將從這一趨勢中受益匪淺。例如，根據澳洲健康與福利研究所2022年7月發布的報告，2021年澳洲報告了超過471,000例COVID-19病例，其中約80,000例披衣菌感染病例、6,000例病例和37,000例曲狀桿菌病例。疾病。因此，感染疾病的增加是推動免疫診斷市場成長的關鍵因素。

醫療保健支出的增加預計將有助於免疫診斷市場的擴大。衛生支出反映了衛生系統和經濟體中與健康相關的商品和服務的總支出，在支持免疫診斷的發展和可及性方面發揮著至關重要的作用。 2022 年 11 月，加拿大健康資訊研究所報告稱，醫療支出繼 2021 年成長 7.6% 後，2022 年將成長 0.8%，達到 3,310 億美元。醫療保健支出的快速成長正在推動免疫診斷市場的成長。

2023年免疫診斷市場最大的地區是北美。免疫診斷市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

全球免疫診斷市場，依產品、性能及預測細分，2018-2023、2023-2028、2033
試劑及耗材
裝置
軟體和服務
全球免疫診斷市場，依技術、效能和預測細分，2018-2023、2023-2028、2033
酵素免疫分析法
化學冷光免疫檢測
螢光免疫分析
免疫測量
快速測試
其他技術
全球免疫診斷市場，按應用、效能和預測細分，2018-2023、2023-2028、2033
感染疾病
腫瘤學和內分泌學
骨骼和礦物質疾病
自體免疫疾病
心臟生物標記
藥物監測
其他用途
全球免疫診斷市場，按最終用戶細分，實際和預測，2018-2023、2023-2028、2033
醫院
診所
診斷實驗室
學術研究所
其他最終用戶

第 7 章區域與國家分析

全球免疫診斷市場，按地區、績效及預測，2018-2023、2023-2028、2033
全球免疫診斷市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭形勢及公司概況

免疫診斷市場競爭形勢
免疫診斷市場公司概況
- Abbott Laboratories
- Arkray Inc.
- bioMerieux Inc.
- Immunodiagnostic Systems Holdings Plc（IDS）
- Bio-Rad Laboratories Inc.

第31章競爭基準化分析

第 32 章競爭對手儀表板

第33章重大併購

第34章未來前景與潛力分析

第35章附錄

簡介目錄

Product Code: r11813

“Immunodiagnostics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunodiagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunodiagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The immunodiagnostics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Reagents And Consumables; Instruments; Software And Services
2) By Technology: Enzyme-Linked Immunosorbent Assay; Chemiluminescence Immunoassay; Fluorescent Immunoassay; Radioimmunoassay; Rapid Test; Other Technologies
3) By Application: Infectious Diseases; Oncology And Endocrinology; Bone And Mineral Diseases; Autoimmunity Disorders; Cardiac Biomarkers; Drug Monitoring; Other Applications
4) By End User: Hospitals; Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End Users
Companies Mentioned: Abbott Laboratories; Arkray Inc.; bioMerieux Inc.; Immunodiagnostic Systems Holdings Plc (IDS); Bio-Rad Laboratories Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Immunodiagnostics is a diagnostic approach that relies primarily on the antigen-antibody response for detecting serum insulin. These tests are employed to identify antibodies and parasite antigens.

The principal products in the field of immunodiagnostics include reagents and consumables, instruments and software, and services. Reagents are substances used to initiate chemical reactions with other substances to detect the presence of specific substances, while consumables refer to traceable items utilized in the execution of analysis techniques. The technologies involved encompass enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, rapid tests, and others. These technologies find applications in various medical fields such as infectious diseases, oncology, endocrinology, bone and mineral diseases, autoimmunity disorders, cardiac biomarkers, drug monitoring, and more. The end-users of immunodiagnostics include hospitals, clinics, diagnostic laboratories, academic and research institutes, among others.

The immunodiagnostics market research report is one of a series of new reports from The Business Research Company that provides immunodiagnostics market statistics, including immunodiagnostics industry global market size, regional shares, competitors with immunodiagnostics market share, detailed immunodiagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the immunodiagnostics industry. This immunodiagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The immunodiagnostics market size has grown strongly in recent years. It will grow from $21.3 billion in 2023 to $22.9 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The expansion observed in the historical period can be attributed to the increasing incidence of infectious diseases, the rise in autoimmune diseases, the diagnosis and monitoring of cancer, the globalization of infectious diseases, and the implementation of public health initiatives and screening programs.

The immunodiagnostics market size is expected to see strong growth in the next few years. It will grow to $30.9 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The anticipated growth in the forecast period can be attributed to preparedness and response to pandemics, advancements in personalized medicine and biomarker discovery, the expansion of healthcare infrastructure in emerging markets, integration with laboratory information systems, and the increasing burden of chronic diseases. Key trends expected in the forecast period involve the adoption of multiplexing technologies, the emergence of point-of-care testing (POCT), advancements in biomarker discovery and personalized medicine, the rise of digital immunodiagnostics, and a shift towards liquid biopsy.

The anticipated increase in the prevalence of infectious diseases is poised to drive the growth of the immunodiagnostics market in the foreseeable future. Infectious diseases, characterized by the transmission of germs such as viruses, bacteria, fungi, or parasites among individuals, can be identified using immunodiagnostic assays that detect the presence of viruses in blood samples. The immunodiagnostics market is expected to benefit significantly from this trend. For example, a report by the Australian Institute of Health and Welfare in July 2022 revealed over 471,000 reported COVID-19 cases in Australia in 2021, along with approximately 86,000 cases of chlamydia and a rise to 37,000 cases of campylobacter, a gastrointestinal illness. Thus, the increasing prevalence of infectious diseases is a major driver for the growth of the immunodiagnostics market.

The upward trajectory in healthcare expenditure is foreseen to contribute to the expansion of the immunodiagnostics market. Healthcare expenditure, reflecting the total spending on healthcare-related goods and services within a healthcare system or economy, plays a pivotal role in supporting the development and accessibility of immunodiagnostics. In November 2022, the Canadian Institute for Health Information reported a 0.8% increase in healthcare expenditure to $331 billion in 2022, following a 7.6% rise in 2021. This surge in healthcare expenditure is instrumental in propelling the growth of the immunodiagnostics market.

Technological advancement emerges as a prominent trend in the immunodiagnostics market, with major companies focusing on the development of innovative technologies to maintain their market position. Cavidi AB, a Sweden-based developer of viral load solutions, introduced Exazym in May 2021. This signal-generating technology enhances the sensitivity of conventional immunodiagnostic assays, allowing for ultra-sensitive detection levels. Cavidi Exazym is poised to enhance research, health screenings, and diagnostic testing, enabling the detection of biomarkers beyond the capabilities of existing diagnostic techniques.

Major companies in the immunodiagnostics market are increasingly forming partnerships to drive revenues. Collaborations involving medical experts, academic entities, and IT firms can significantly contribute to market expansion by fostering innovation and accelerating clinical immunodiagnostics. For example, in October 2022, Telix Pharmaceuticals Limited, an Australia-based radiopharmaceutical company, partnered with GE Healthcare, a US-based medical technology company, to combine Telix's investigational PET imaging radiotracers with GE Healthcare's immuno-diagnostic range. This collaboration aims to improve therapy selection and patient monitoring in immunotherapy trials.

In July 2021, DiaSorin S.p.A., an Italy-based biotechnology company, acquired Luminex Corporation for $1.8 billion. This strategic move granted DiaSorin access to Luminex's multiplexing technology and expanded its portfolio, reinforcing its position in the United States. Luminex Corporation, based in the US, is known for developing, manufacturing, and selling proprietary biological testing technologies and products across life sciences, transplant research, and immunodiagnostics.

Major companies operating in the immunodiagnostics market report are Abbott Laboratories, Arkray Inc., bioMerieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation

North America was the largest region in the immunodiagnostics market in 2023. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunodiagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunodiagnostics market consists of revenues earned by entities by providing agglutination, nephelometry, immunoprecipitation, and radial immunodiffusion test services. The market value includes the value of related goods sold by the service provider or included within the service offering. The immunodiagnostics market also includes sales of anti-streptolysin-O latex, infectious mononucleosis slide, rheumatoid factor, and syphilis serology reagent. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

1. Executive Summary

2. Immunodiagnostics Market Characteristics

3. Immunodiagnostics Market Trends And Strategies

4. Immunodiagnostics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Immunodiagnostics Market Size and Growth

5.1. Global Immunodiagnostics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Immunodiagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Immunodiagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Immunodiagnostics Market Segmentation

6.1. Global Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Reagents And Consumables
Instruments
Software And Services
6.2. Global Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Enzyme-Linked Immunosorbent Assay
Chemiluminescence Immunoassay
Fluorescent Immunoassay
Radioimmunoassay
Rapid Test
Other Technologies
6.3. Global Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Infectious Diseases
Oncology And Endocrinology
Bone And Mineral Diseases
Autoimmunity Disorders
Cardiac Biomarkers
Drug Monitoring
Other Applications
6.4. Global Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Diagnostic Laboratories
Academic And Research Institutes
Other End Users

7. Immunodiagnostics Market Regional And Country Analysis

7.1. Global Immunodiagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Immunodiagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Immunodiagnostics Market

8.1. Asia-Pacific Immunodiagnostics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Immunodiagnostics Market

9.1. China Immunodiagnostics Market Overview
9.2. China Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Immunodiagnostics Market

10.1. India Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Immunodiagnostics Market

11.1. Japan Immunodiagnostics Market Overview
11.2. Japan Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Immunodiagnostics Market

12.1. Australia Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Immunodiagnostics Market

13.1. Indonesia Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Immunodiagnostics Market

14.1. South Korea Immunodiagnostics Market Overview
14.2. South Korea Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Immunodiagnostics Market

15.1. Western Europe Immunodiagnostics Market Overview
15.2. Western Europe Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Immunodiagnostics Market

16.1. UK Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Immunodiagnostics Market

17.1. Germany Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Immunodiagnostics Market

18.1. France Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Immunodiagnostics Market

19.1. Italy Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Immunodiagnostics Market

20.1. Spain Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Immunodiagnostics Market

21.1. Eastern Europe Immunodiagnostics Market Overview
21.2. Eastern Europe Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Immunodiagnostics Market

22.1. Russia Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Immunodiagnostics Market

23.1. North America Immunodiagnostics Market Overview
23.2. North America Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Immunodiagnostics Market

24.1. USA Immunodiagnostics Market Overview
24.2. USA Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Immunodiagnostics Market

25.1. Canada Immunodiagnostics Market Overview
25.2. Canada Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Immunodiagnostics Market

26.1. South America Immunodiagnostics Market Overview
26.2. South America Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Immunodiagnostics Market

27.1. Brazil Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Immunodiagnostics Market

28.1. Middle East Immunodiagnostics Market Overview
28.2. Middle East Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Immunodiagnostics Market

29.1. Africa Immunodiagnostics Market Overview
29.2. Africa Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Immunodiagnostics Market Competitive Landscape And Company Profiles

30.1. Immunodiagnostics Market Competitive Landscape
30.2. Immunodiagnostics Market Company Profiles
- 30.2.1. Abbott Laboratories
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Arkray Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. bioMerieux Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Immunodiagnostic Systems Holdings Plc (IDS)
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bio-Rad Laboratories Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Immunodiagnostics Market Competitive Benchmarking

32. Global Immunodiagnostics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Immunodiagnostics Market

34. Immunodiagnostics Market Future Outlook and Potential Analysis

34.1 Immunodiagnostics Market In 2028 - Countries Offering Most New Opportunities
34.2 Immunodiagnostics Market In 2028 - Segments Offering Most New Opportunities
34.3 Immunodiagnostics Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies